Risk Management Only Part Of Behind-The-Counter Orders – Von Eschenbach

Enactment of legislation to strengthen FDA's post-marketing authority is not the only hurdle to clear before the agency could begin requiring behind-the-counter sales of certain nonprescription drugs, Commissioner Andrew von Eschenbach says

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet